As the number of asthmatics, COPD, and allergy patients continues to grow, the upper respiratory treatment market is attracting a number of new companies – companies with some novel approaches to the problem of chronic airway inflammation. These companies are conducting ongoing........more

Combination inhalers are relied upon by 300 million worldwide for the treatment of debilitating and life-threatening respiratory conditions. For the majority of these patients, the device in their pockets, purses, and cabinets has been and is the metered dose inhaler. Metered dose inhalers have gone through........more

The pace and number of new inhalation delivery candidates entering the drug development pipeline is accelerating. For inhalation device suppliers and their drug partners, understanding the concerns, preferences, and limitations of consumers to self-medicate via inhalation will be the driving force for future ........more

The convergence of socioeconomic and technology factors – the growing emphasis on drug self-administration for chronic conditions, the expected acceleration in protein- and peptide-based therapeutics, the availability of innovative dry powder inhalation devices with unique .......more